Isbn: 9786206142935 - bioequivalence study of ranolazine1000 mg tablets (5 risultati)

Perfeziona la tua ricerca

  • Libri (5)

  • Nuovo (5)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2023

    6206142930 / 9786206142935

    • Brossura

    Da: preigu, Osnabrück, Germaniapreigu

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 58,75

    EUR 70,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 5 disponibili

    Taschenbuch. Condizione: Neu. Bioequivalence Study Of Ranolazine1000 Mg Tablets | V. Jhansi Lakshmi | Taschenbuch | Englisch | 2023 | LAP LAMBERT Academic Publishing | EAN 9786206142935 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing Mrz 2023, 2023

    6206142930 / 9786206142935

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 68,90

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Bioavailability (BA) & Bioequivalence (BE) studies fortifies equality in standards of safety, efficacy and quality of pharmaceutical products. Bioavailability is for the most part recorded by a foundational presentation profile got by estimating drugs or potentially metabolites focus in the fundamental flow after some time. Bioequivalence studies are about conducted for the comparing two medicinal substances those accommodate aforementioned active substances. The bioavailability of activating actuality from a Pharmaceutical account care to be accepted and reproducible. Bioavailability and bioequivalence information is subsequently required to be outfitted with NDA & ANDA, as required under schedule Y, contingent upon the kind of use being submitted. 132 pp. Englisch.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2023

    6206142930 / 9786206142935

    • Brossura
    • Print on Demand

    Da: moluna, Greven, Germaniamoluna

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 53,35

    EUR 48,99 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Lakshmi V. JhansiI am Mrs V. Jhansi Lakshmi working as Assistant Professor in Vignan institute of Pharmaceutical technologyBioavailability (BA) & Bioequivalence (BE) studies fortifies equality in standards of safety, efficacy and.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2023

    6206142930 / 9786206142935

    • Brossura
    • Print on Demand

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 98,14

    EUR 30,50 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Bioavailability (BA) & Bioequivalence (BE) studies fortifies equality in standards of safety, efficacy and quality of pharmaceutical products. Bioavailability is for the most part recorded by a foundational presentation profile got by estimating drugs or potentially metabolites focus in the fundamental flow after some time. Bioequivalence studies are about conducted for the comparing two medicinal substances those accommodate aforementioned active substances. The bioavailability of activating actuality from a Pharmaceutical account care to be accepted and reproducible. Bioavailability and bioequivalence information is subsequently required to be outfitted with NDA & ANDA, as required under schedule Y, contingent upon the kind of use being submitted.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing Mär 2023, 2023

    6206142930 / 9786206142935

    • Brossura
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 68,90

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Bioavailability (BA) & Bioequivalence (BE) studies fortifies equality in standards of safety, efficacy and quality of pharmaceutical products. Bioavailability is for the most part recorded by a foundational presentation profile got by estimating drugs or potentially metabolites focus in the fundamental flow after some time. Bioequivalence studies are about conducted for the comparing two medicinal substances those accommodate aforementioned active substances. The bioavailability of activating actuality from a Pharmaceutical account care to be accepted and reproducible. Bioavailability and bioequivalence information is subsequently required to be outfitted with NDA & ANDA, as required under schedule Y, contingent upon the kind of use being submitted.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 132 pp. Englisch.